Reduced GST on cancer drugs : Step towards greater affordability

The government announcement of slashing GST on cancer drugs has been one of the long standing demands of the healthcare industry and is seen as a positive step for a segment which predominantly relies on imports but with more than 1.4 million cancer cases which are expected to grow further at a annual growth rate of 12.8 per cent quintessentially requires a robust ecosystem to fight the inflating load.

from Top Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/l24EAKZ
via